Form 4: MicroVision Director Carlile's Stock Vesting

MicroVision Director Robert Paul Carlile acquired 22,007 shares of common stock through the vesting of restricted stock units.

Summary

• Robert Paul Carlile, a Director at MicroVision, Inc. (MVIS), acquired 22,007 shares of common stock on December 1, 2025.
• These shares were obtained through the vesting of restricted stock units (RSUs) without payment, converting on a unit-for-share basis.
• Following this transaction, Carlile beneficially owns 328,792 shares of common stock directly.
• The RSUs were granted on June 6, 2025, and are scheduled to vest in four equal quarterly installments.
• Full vesting is set for the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on continued service as a director.
• A previous Form 4 filed on June 6, 2025, incorrectly reported the total RSUs granted on June 5, 2025, as 87,462 RSUs; the correct amount was 88,208 RSUs, though the vesting reported herein was calculated based on 88,028 RSUs.

Sentiment

Score: 6

Explanation: The filing reports a routine, expected vesting of equity compensation for a director, which is generally a neutral event. The correction of a previous reporting error introduces a minor negative aspect regarding data accuracy, but the overall impact is limited to insider ownership changes.

Positives

• Director Carlile's increased direct ownership of 22,007 common shares aligns his interests with shareholders.
• The vesting of RSUs indicates his continued service as a director, fulfilling the conditions of the equity compensation plan.

Negatives

• A previous Form 4 filing contained an incorrect reporting of the total RSU grant amount, requiring a correction in this filing.

Risks

• The vesting of the remaining Restricted Stock Units is contingent on Robert Paul Carlile continuing to serve as a director through each vesting date.

Future Outlook

The RSUs granted on June 6, 2025, are scheduled to vest in four equal quarterly installments, with full vesting occurring on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided the director continues to serve.

Management Comments

• Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
• At vesting, RSUs convert into shares of common stock on a unit-for-share basis, without payment.
• RSUs granted 06/06/2025 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date.
• The Form 4 filed on 06/06/2025 incorrectly reported the total RSUs granted on 06/05/2025 as 87,462 RSUs instead of the correct amount of 88,208 RSUs. The vesting reported herein was calculated based on the correct amount of 88,028 RSUs.

Industry Context

This is an insider transaction filing (Form 4), which is standard for reporting changes in beneficial ownership by company insiders. It reflects routine equity compensation vesting for a director, rather than a strategic business announcement impacting broader industry trends or competitive landscape.

Comparison to Industry Standards

• Equity compensation in the form of Restricted Stock Units (RSUs) is a common practice across various industries for attracting and retaining executive talent and directors, aligning their interests with long-term shareholder value.
• The vesting schedule, tied to continued service, is a standard mechanism to ensure retention and performance incentives, comparable to practices at technology companies like Apple, Microsoft, or Google, which frequently use RSUs for executive compensation.
• The correction of a previous filing, while not ideal, is a standard regulatory requirement for ensuring accuracy in public disclosures, similar to how other publicly traded companies rectify errors in their SEC filings.

Stakeholder Impact

• Shareholders: Director Carlile's increased direct ownership aligns his interests with shareholders, potentially signaling confidence. The correction of a previous filing ensures accurate disclosure.
• Employees: No direct impact on general employees.

Next Steps

• Future quarterly installments of the RSUs granted on June 6, 2025, are expected to vest, contingent on the director's continued service.
• The remaining RSUs are scheduled to be fully vested by the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders.

Key Dates

Recommendation

This Form 4 filing details a routine vesting of restricted stock units for a director, which is an expected part of executive compensation. It does not present new information that would fundamentally alter the investment thesis for MicroVision, Inc. While the director's increased ownership is a minor positive for alignment, the event itself is neutral in terms of company performance or strategic direction. The correction of a prior reporting error is a minor administrative detail. Therefore, a 'hold' recommendation is appropriate as this filing provides no strong catalyst for a buy or sell decision.

Keywords

MicroVision, MVIS, Form 4, Insider Transaction, Stock Vesting, Restricted Stock Units, Director Compensation, Equity Compensation, Beneficial Ownership